Investment Q&A

Q: 11:08 AM 7/21/2020

Would you please comment on the future viability of Royal Caribbean International and Celebrity Cruises RCL.

Given the ongoing worldwide Covid crisis it seems to me unlikely that this company or any other Cruise line can continue to operate.

They hold a vast amount of cash as prepaid cruises by customers, most of which they will have to eventually return or write off in bankruptcy or reorganization. They say that the cruises are just "deferred" till 2021 but Covid will roll on and most customers will never go back. Will this tip the company over the edge?

May 20, 2020 you said " We would go to RCL in a 'gamble' scenario." That the share price up $12 since then surprises me.

How huge is their debt now, and do they have any meaningful ability to service it. Would you invest in this company now? Their present income must be about nil. Looks to me like a binary outcome...... brilliant investment or bankruptcy.

Thank you......... Paul K.

Q: In my research on the 5g buildout , I came across Macom Technology Solutions ( MTSI ) and compared performance for 3 months and 12 months to other high fliers like, AAPL, ATVI, NVDA , QCOM , as well as comparing T-Mobile to Verizon. . I had never heard of Macom and Iyou have never mentioned it. Have you any thoughts on this MTSI , or am I better to limit my choices to better known entities ? Thanks

Q: Hello,
I couldn't find any questions on this ETF. PTH Invesco Healthcare ETF
Could I have your pros and cons list please?
Dave

Q: Hi,
SVA & AZN are both in phase 3 of COVID-19 vaccine.
What are your thoughts about these companies?
Which one has the better financial ability to see the end of the vaccine development, approval and production of the vaccine (if their vaccine will prove itself successful).
Thanks,
Morris

Q: Hello 5I:
With the big push in the USA for a vaccine for Covid-19 and supporting some companies with funding for research, which would you purchase and why for a speculative purchase....Moderna, Novavax or both. Thanks for your great advice.

Q: These are all down about 40% from their recent highs. Do you have any concerns with the sector in general? Which two would you pick for bounce back potential?

Q: What is the consensus view for MSFt earnings and revenues tomorrow when they report? Thank you.

Q: I would like your thoughts on duke energy
For a 3 to 5 year pick
Thanks
Sam

Q: Looking at the top ten holdings of the TAN solar etf...can you comment on some of them based on your 5iresearch criteria....sedg, enph, fslr, run, Dq, csiq

Q: While it is difficult to pull away from my tech holdings, to diversify some US holdings I am considering purchases of Treehouse and Northrop Grumann. Even though these are USA stocks, if possible, would you please give your analysis of whether these companies are good investments at this time...are they a buy or not, and why? Thank you for your excellent service.

Q: Your thoughts on ZI, which has pulled back recently. Would you step in here?

Thanks

Dave

Q: Can you give me your opinion on this company and if it’s a buy right now please?

Q: I am looking at US Healthcare (with the exception of WELL), how would you rank these companies in when considering balance sheet, management, growth potential, and MOAT?

Thanks,

Andrew

Q: What would be your take on Cura
Thanks Phil

Q: As the world recovers from COVID it would seem that there be de-globalization, deeping China trade wars as the world unites against Chinese tactics, on-shoring of certain industries, a bit of "protectionism", etc. Theses are broad assumptions and if true would IWO be a good bet if those assumptions came to be? Thanks Ron

Q: I have only one US Tech stock QCOM and have done well with it. However, I would like to reduce or replace it with a couple of other US Tech stocks. What do you suggest? I already have CSU and KXS in my CDN portfolio.

Q: Hello Peter,
Any of the above mentioned stocks you would consider rotating out of/reduce in favour of buying some value such as GE, KHC or any other that you would suggest?

Q: I notice that you both hold VZ and are generally positive about it, and conversely are generally negative in regard to AT&T.
I hold neither of these stocks at this time, but have been thinking about getting back into one of them.
Interestingly, Standard and Poore's rates VZ a sell and T a buy.
Beyond "that's what makes a market", any comments in defense of your position. Thanks.

Q: Can you provide your thoughts on these three growth stocks? Any concerns?

Q: I have no medical training nor have I worked in the field of medical research.
I do, however, have some knowledge of that area and have followed advances for several decades.
What thoroughly stunned me was the discovery of CRISPR-Cas9 in the field of genetic engineering as well as our current ability to design molecules for use as therapeutics.
I have no doubt as to the success that will come in these areas. What stopped me from investing in them was the fact that so many people were working in these fields that choosing the wrong company seemed very possible. For example, who wants to buy the 3rd best cure for a disease threatening one of their own family. The many possible cures and therapies being investigated for Covid are examples of this.
It's rather like living in the early 20th century and becoming convinced that automobiles and airplanes might have a bright future, then going out and buying stock in Packard, Studebaker, Nash, Rambler, Hudson, etc. The list of failures goes on and on.
I finally bit on ABBV and CRISP just as we descended into Covid hell but not at the bottom. I chose ABBV for their expertise in therapeutics and CRSP for gene editing.
Fortunately I'm not asking you to comment on the technologies involved but rather on your impression of the abilities of both companies to manage their businesses. What are their cash reserves like? What's their current burn rate? When might they be next raising capital; that sort of thing.

In my earlier days I bought several positions in some truly impressive inventions. One actually resulted in several world records. Unfortunately they could neither manufacture nor sell the product. In fact some companies couldn't sell life preservers to a drowning man. The end is obvious. They went bankrupt.

Finally, you don't seem to include CRSP in your top picks in this area. I'm curious why. Don't like it, too many others to choose from or its European base?